Evidence map›Paper›PMID 41737954›Full record

ArticleJAC-antimicrobial resistance2026

Mechanisms of fosfomycin resistance observed in clinical isolates of

Laura F Mataseje, Cole Lysak, Nicole Lerminiaux, Melanie Baxter, James A Karlowsky, George G Zhanel

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura F MatasejeNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Cole LysakDepartment of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.
Nicole LerminiauxNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.ORCID https://orcid.org/0000-0001-7914-9198
Melanie BaxterDepartment of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.
James A KarlowskyDepartment of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.
George G ZhanelDepartment of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral fosfomycin is commonly prescribed as a single 3 g dose to empirically treat uncomplicated cystitis. This study investigated the mechanisms and frequency of fosfomycin resistance among clinical isolates of Methods: In total, 5012 clinical isolates of Results: In total, 98.7% (4948/5012) of all Conclusions: In Canada, the occurrence of mobile fosfomycin resistance determinants (

Identifiers

PMID41737954
PMCPMC12926222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.